Wan YP - Search Results

1

Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.

Haskell-Luevano C, Cone RD, Monck EK, Wan YP. Haskell-Luevano C, et al. Among authors: wan yp. Biochemistry. 2001 May 22;40(20):6164-79. doi: 10.1021/bi010025q. Biochemistry. 2001. PMID: 11352754

2

Haskell-Luevano C, Monck EK, Wan YP, Schentrup AM. Haskell-Luevano C, et al. Among authors: wan yp. Peptides. 2000 May;21(5):683-9. doi: 10.1016/s0196-9781(00)00194-7. Peptides. 2000. PMID: 10876051

3

From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.

Murugaiah AM, Wu X, Wallinder C, Mahalingam AK, Wan Y, Sköld C, Botros M, Guimond MO, Joshi A, Nyberg F, Gallo-Payet N, Hallberg A, Alterman M. Murugaiah AM, et al. J Med Chem. 2012 Mar 8;55(5):2265-78. doi: 10.1021/jm2015099. Epub 2012 Feb 22. J Med Chem. 2012. PMID: 22248302

4

Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.

Wu X, Wan Y, Mahalingam AK, Murugaiah AM, Plouffe B, Botros M, Karlén A, Hallberg M, Gallo-Payet N, Alterman M. Wu X, et al. J Med Chem. 2006 Nov 30;49(24):7160-8. doi: 10.1021/jm0606185. J Med Chem. 2006. PMID: 17125268

5

Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.

Murugaiah AM, Wallinder C, Mahalingam AK, Wu X, Wan Y, Plouffe B, Botros M, Karlén A, Hallberg M, Gallo-Payet N, Alterman M. Murugaiah AM, et al. Bioorg Med Chem. 2007 Nov 15;15(22):7166-83. doi: 10.1016/j.bmc.2007.07.026. Epub 2007 Aug 22. Bioorg Med Chem. 2007. PMID: 17825570

6

Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.

Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam AK, Wu X, Johansson B, Holm M, Botoros M, Karlén A, Pettersson A, Nyberg F, Fändriks L, Gallo-Payet N, Hallberg A, Alterman M. Wan Y, et al. J Med Chem. 2004 Nov 18;47(24):5995-6008. doi: 10.1021/jm049715t. J Med Chem. 2004. PMID: 15537354

7

Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.

Mahalingam AK, Wan Y, Murugaiah AM, Wallinder C, Wu X, Plouffe B, Botros M, Nyberg F, Hallberg A, Gallo-Payet N, Alterman M. Mahalingam AK, et al. Bioorg Med Chem. 2010 Jun 15;18(12):4570-90. doi: 10.1016/j.bmc.2010.03.064. Epub 2010 Apr 9. Bioorg Med Chem. 2010. PMID: 20493713

8

First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo.

Wan Y, Wallinder C, Johansson B, Holm M, Mahalingam AK, Wu X, Botros M, Karlén A, Pettersson A, Nyberg F, Fändriks L, Hallberg A, Alterman M. Wan Y, et al. J Med Chem. 2004 Mar 11;47(6):1536-46. doi: 10.1021/jm031031i. J Med Chem. 2004. PMID: 14998339

9

Study on the molecular mechanisms of rifaximin in the treatment of non‑alcoholic steatohepatitis based on the Helicobacter‑DCA‑Fxr‑Hnf1α signalling pathway.

Wan YP, Li S, Li D, Huang XM, Wu JH, Jian J. Wan YP, et al. Mol Med Rep. 2025 Feb;31(2):42. doi: 10.3892/mmr.2024.13407. Epub 2024 Nov 29. Mol Med Rep. 2025. PMID: 39611479 Free PMC article.

10

[A case of Wilson's disease misdiagnosed as autoimmune hepatitis and literature review].

Chen LF, Wan YP, Xiao LM, Li D, Wen ZL, Yang LL. Chen LF, et al. Among authors: wan yp. Zhonghua Gan Zang Bing Za Zhi. 2024 Nov 11;32:1-5. doi: 10.3760/cma.j.cn501113-20240411-00193. Online ahead of print. Zhonghua Gan Zang Bing Za Zhi. 2024. PMID: 39528314 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters